Analysis of prothrombotic mechanisms and endothelial perturbation during treatment with angiogenesis inhibitors.
Kuenen
Bart C
BC
Department of Medical Oncology, VUMC, University of Amsterdam, Amsterdam, The Netherlands. b.kuenen@vumc.nl
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D011758:Pyrroles / Q000009:adverse effects / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced; D019851:Thrombophilia / Q000139:chemically induced*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; C116890:Semaxinib